"Pulmonary Surfactants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI.
| Descriptor ID |
D011663
|
| MeSH Number(s) |
D27.505.954.796.600
|
| Concept/Terms |
Pulmonary Surfactants- Pulmonary Surfactants
- Surfactants, Pulmonary
- Pulmonary Surfactant
- Surfactant, Pulmonary
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Surfactants".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Surfactants".
This graph shows the total number of publications written about "Pulmonary Surfactants" by people in this website by year, and whether "Pulmonary Surfactants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 3 | 2 | 5 |
| 2018 | 1 | 3 | 4 |
| 2019 | 3 | 0 | 3 |
| 2020 | 2 | 1 | 3 |
| 2021 | 3 | 1 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Pulmonary Surfactants" by people in Profiles.
-
Nanoparticle-mediated surfactant therapy in patients with severe COVID-19: a perspective. J Mater Chem B. 2021 09 15; 9(35):6988-6993.
-
Video-based reflection on neonatal interventions during COVID-19 using eye-tracking glasses: an observational study. Arch Dis Child Fetal Neonatal Ed. 2022 Mar; 107(2):156-160.
-
Beneficial effects of inhaled surfactant in patients with COVID-19-associated acute respiratory distress syndrome. Respir Med. 2021 Aug-Sep; 185:106489.
-
Concomitant use of surfactant and extra-corporeal membrane oxygenation for COVID-19 in an 8-year-old boy. Minerva Cardiol Angiol. 2021 10; 69(5):620-621.
-
Current evidence for prenatal and postnatal corticosteroids in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2022 Mar; 107(2):121-125.
-
Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury. Respir Physiol Neurobiol. 2021 06; 288:103645.
-
Proposal of selective wedge instillation of pulmonary surfactant for COVID-19 pneumonia based on computational fluid dynamics simulation. BMC Pulm Med. 2021 Feb 22; 21(1):62.
-
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection. Med Hypotheses. 2021 04; 149:110529.
-
Surfactant for the Treatment of ARDS in a Patient With COVID-19. Chest. 2021 07; 160(1):e9-e12.
-
Surfactant therapy for COVID-19 related ARDS: a retrospective case-control pilot study. Respir Res. 2021 Jan 18; 22(1):20.